Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers November 23, 2017
Pharmacy Choice - Pharmaceutical News - US Generic Drug Market 2017-2022: Patent Expiry of Blockbuster Drugs, Price Differential between Generics and Innovator Drugs, Incentives for Dispensing and Prescribing Generic Drugs - November 23, 2017

Pharmacy News Article

 4/20/17 - US Generic Drug Market 2017-2022: Patent Expiry of Blockbuster Drugs, Price Differential between Generics and Innovator Drugs, Incentives for Dispensing and Prescribing Generic Drugs

Dublin - Research and Markets has announced the addition of the "US Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report to their offering.

The US generic drug market has witnessed a transformation over the last three decades. From less than 20% of the total prescriptions, generic drugs now account for the majority of the total prescriptions dispensed in the United States.

During 2010-2016, the US generic drug market grew at a CAGR of more than 13% and currently represents a multibillion dollar industry. The biggest catalyst of this industry is the significantly lower price of generics compared to branded drugs. Although generics are chemically identical to their branded counterparts, they are typically sold at substantial discounts from the branded price.

This has enabled governments and third-party payers to save billions of dollars in healthcare expenditures and resulted in lower copayments for patients. Other factors such as patent expiration of blockbuster innovator drugs, ageing population and an increasing prevalence of chronic diseases have also acted as catalysts for this market.

Key Topics Covered:

1 Preface

2 Research Methodology and Market Definitions

3 Executive Summary

4 US Generic Drug Market - Introduction

5 Why is the US Generic Drug Market so Lucrative

6 Global Generic Drug Market

7 US Generic Drug Market

8 SWOT Analysis

9 US Generic Drug Market - Value Chain Analysis

10 Pricing Mechanism and Profit Margins at Various Levels of the Supply Chain

11 Porter's Five Forces Analysis

12 US Generic Drug Market- Competitive Landscape

13 Regulations in the US Generic Drug Industry

14 US Generic Drug Market: Key Success Factors

15 US Generic Drug Market: Road Blocks

16 Requirements for Setting Up a Generic Drug Manufacturing Plant

17 Key Company Profiles

- Actavis

- Dr Reddy's

- Endo Pharmaceuticals

- Hospira

- Lupin Pharmaceuticals

- Mylan

- Par Pharmaceuticals

- Sandoz

- Sun Pharma

- Teva

For more information about this report visit http://www.researchandmarkets.com/research/ht2bss/us-generic-drug

CONTACT:

Research and Markets,

Laura Wood,

Senior Manager.

press@researchandmarkets.com

Fax from USA: 646-607-1907

Fax from rest of the world: +353-1-481-1716

Related Topics: Generic Drugs (http://www.researchandmarkets.com/categories.asp?cat-id=118&campaign-id=ht2bss)

.



(c) 2017 M2 COMMUNICATIONS

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Nov 27: Drug Diversion and the Law: Updates and Considerations
Nov 28: An Integrative Approach to Managing Arthritis
Nov 29: Influenza 2017-2018: An Update on Prevention and Treatment
Nov 30: School is Out! Life is in Session: The Importance of Professional Development in Pharmacy
Dec 01: Anticoagulants: The Rapidly Changing Landscape
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415